- KDMN Dashboard
- Financials
- Filings
-
Holdings
-
Transcripts
-
ETFs
- Insider
- Institutional
- Shorts
-
8-K Filing Data
Kadmon (KDMN) 8-K10 Mar 21Kadmon Announces U.S. FDA has Extended the Review Period for Belumosudil in Chronic Graft-Versus-Host DiseaseFinancial data
Company Profile